                         SEQUENCE LISTING

<110>  Kiromic, LLC
 
<120>  Methods and Compositions for Treating Cancer with Dendritic Cells

<130>  5091-0016-PCT

<150>  62/146,502
<151>  2015-04-13

<160>  15    

<170>  PatentIn version 3.5

<210>  1
<211>  13
<212>  PRT
<213>  human

<400>  1

Met Pro Lys Lys Lys Pro Thr Pro Ile Gln Leu Asn Pro 
1               5                   10              


<210>  2
<211>  31
<212>  DNA
<213>  synthetic

<400>  2
agatctatgt cgattccttt ctccaacacc c                                      31


<210>  3
<211>  31
<212>  DNA
<213>  synthetic

<400>  3
ctcgagtcaa ttgtctgcct cttctttcag a                                      31


<210>  4
<211>  22
<212>  DNA
<213>  synthetic

<400>  4
atggatgacg atatcgctgc gc                                                22


<210>  5
<211>  23
<212>  DNA
<213>  synthetic

<400>  5
ggaaccgctc gttgccaata gtg                                               23


<210>  6
<211>  151
<212>  PRT
<213>  human

<400>  6

Met Ser Ile Pro Phe Ser Asn Thr His Tyr Arg Ile Pro Gln Gly Phe 
1               5                   10                  15      


Gly Asn Leu Leu Glu Gly Leu Thr Arg Glu Ile Leu Arg Glu Gln Pro 
            20                  25                  30          


Asp Asn Ile Pro Ala Phe Ala Ala Ala Tyr Phe Glu Ser Leu Leu Glu 
        35                  40                  45              


Lys Arg Glu Lys Thr Asn Phe Asp Pro Ala Glu Trp Gly Ser Lys Val 
    50                  55                  60                  


Glu Asp Arg Phe Tyr Asn Asn His Ala Phe Glu Glu Gln Glu Pro Pro 
65                  70                  75                  80  


Glu Lys Ser Asp Pro Lys Gln Glu Glu Ser Gln Ile Ser Gly Lys Glu 
                85                  90                  95      


Glu Glu Thr Ser Val Thr Ile Leu Asp Ser Ser Glu Glu Asp Lys Glu 
            100                 105                 110         


Lys Glu Glu Val Ala Ala Val Lys Ile Gln Ala Ala Phe Arg Gly His 
        115                 120                 125             


Ile Ala Arg Glu Glu Ala Lys Lys Met Lys Thr Asn Ser Leu Gln Asn 
    130                 135                 140                 


Glu Glu Lys Glu Glu Asn Lys 
145                 150     


<210>  7
<211>  9
<212>  PRT
<213>  human

<400>  7

Ile Leu Asp Ser Ser Glu Glu Asp Lys 
1               5                   


<210>  8
<211>  9
<212>  PRT
<213>  human

<400>  8

Tyr Ala Asp Gln Val Asn Ile Asp Tyr 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  human

<400>  9

Ala Thr Glu Lys Ser Val Lys Thr Lys 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  human

<400>  10

Phe Thr Glu Glu Ile Glu Trp Leu Lys 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  human

<400>  11

Asp Gln Met Glu Glu Glu Glu Phe Ile 
1               5                   


<210>  12
<211>  9
<212>  PRT
<213>  human

<400>  12

Gln Leu Phe Glu Asp Asn Tyr Ala Leu 
1               5                   


<210>  13
<211>  9
<212>  PRT
<213>  human

<400>  13

Phe Leu Val Phe Val Phe Val Phe Leu 
1               5                   


<210>  14
<211>  9
<212>  PRT
<213>  human

<400>  14

Leu Met Trp Ile Thr Gln Cys Phe Leu 
1               5                   


<210>  15
<211>  9
<212>  PRT
<213>  human

<400>  15

Thr Leu Ala Lys Phe Ser Pro Tyr Leu 
1               5                   


